참고문헌
- Basset P, Bellocq JP, Wolf C, et al (1990). A novel Metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature, 348, 699-704. https://doi.org/10.1038/348699a0
- Basset P, Wolf C, Chambon P (1993). Expression of the stromelysin-3 gene in fibroblastic cells of invasive carcinomas of the breast and other human tissues: a review. Breast Cancer Res Treat, 24, 185-93. https://doi.org/10.1007/BF01833259
- Bono AV, Celato N, Cova V, et al (2002). Microvessel density in prostate carcinoma. Prostate Cancer Prostatic Dis, 5, 123-7. https://doi.org/10.1038/sj.pcan.4500572
- Choy M, Rafii S (2001). Role of angiogenesis in the progression and treatment of prostate cancer. Cancer Invest, 19, 181-91. https://doi.org/10.1081/CNV-100000152
- Concato J, Jain D, Uchio E, et al (2009). Molecular markers and death from prostate cancer. Ann Intern Med, 150, 595-603. https://doi.org/10.7326/0003-4819-150-9-200905050-00005
- Condon MS (2005). The role of the stromal microenvironment in prostate cancer. Sem Cancer Biol, 15, 132-7. https://doi.org/10.1016/j.semcancer.2004.08.002
- Deryugina EI, Quigley JP (2015). Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasissustaining neovasculature. Matrix Biol, (in press).
- Erbersdobler A, Isbarn H, Dix K (2010). Prognostic value of microvessel density in prostate cancer: a tissue microarray study. World J Urol, 28, 687-92. https://doi.org/10.1007/s00345-009-0471-4
- Escaff S, Fernandez JM, Gonzalez LO, et al (2010). Study of matrix metalloproteinases and their inhibitors in prostate cancer. Br J Cancer, 102, 922-9. https://doi.org/10.1038/sj.bjc.6605569
- Fidler IJ, Ellis LM, (1994). The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell, 79, 185-8. https://doi.org/10.1016/0092-8674(94)90187-2
- Folkman J (1971). Tumor angiogenesis: therapeutic implications. N Engl J Med, 285, 1182-6. https://doi.org/10.1056/NEJM197111182852108
- Folkman J (1990). What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst, 82, 4-6. https://doi.org/10.1093/jnci/82.1.4
- Folkman J (1992). The role of angiogenesis in tumor growth. Semin Cancer Biol, 3, 65-71.
- Folkman J, Watson K, Ingber D, et al (1989). Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature, 339, 58-61. https://doi.org/10.1038/339058a0
- Gimbrone MA Jr, Leapman SB, Cotran RS, et al (1972). Tumor dormancy in vivo by prevention of neovascularization. J Exp Med, 136, 261-76. https://doi.org/10.1084/jem.136.2.261
- Globocan (2012). Prostate cancer: estimated incidence, mortality and prevalence worldwide in 2012 [Online]. Available:http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx.
- Iakovlev VV, Gabril M, Dubinski W, et al (2012). Microvascular density as an independent predictor of clinical outcome in renal cell carcinoma: an automated image analysis study. Laboratory Investigation, 92, 46-56. https://doi.org/10.1038/labinvest.2011.153
- Kaygusuz G, Tulunay O, Baltaci S, et al (2007). Microvessel density and regulators of angiogenesis in malignant and nonmalignant prostate tissue. Int Urol Nephrol, 39, 841-50. https://doi.org/10.1007/s11255-006-9144-z
- Kessenbrock K, Plaks V, Werb (2010). Matrix Metalloproteinases: Regulators of the Tumor Microenvironment. Cell, 141, 52-67. https://doi.org/10.1016/j.cell.2010.03.015
- Khuhaprema T, Srivatanakul P, Attasara P, et al (2013). Cancer in Thailand Volume VII 2007-2009. National cancer institute, 7, 12.
- Lin CW, Yang SF, Chuang CY, et al (2014). Association of matrix metalloproteinase-11 polymorphisms with susceptibility and clinicopathologic characteristics for oral squamous cell carcinoma. Head Neck, DOI: 10.1002/hed.23771.
- Manes S, Mira E, Barbacid MD, et al (1997). Identification of insulin-like growth factor-binding protein-1 as a potential physiological substrate for human stromelysin-3. J Biol Chem, 272, 25706-12. https://doi.org/10.1074/jbc.272.41.25706
- Min KW, Kim DH, Do SI, et al (2013). Diagnostic and prognostic relevance of MMP-11 expression in the stromal fibroblastlike cells adjacent to invasive ductal carcinoma of the breast. Ann Surg Oncol, 20, 433-42. https://doi.org/10.1245/s10434-012-2734-3
- Montironi R, Diamanti L, Thompson D, et al (1996). Analysis of the capillary architecture in the precursors of prostate cancer: recent findings and new concepts. Eur Urol, 30, 191-200.
- Murphy G, Segain JP, O'Shea M, et al (1993). The 28-kDa N-terminal domain of mouse stromelysin-3- has the general properties of a weak metalloproteinase. J Biol Chem, 268, 15435-41.
- Nagase H, Woesser JF Jr (1999). Matrix metalloproteinases. J Bio Chem, 274, 21491-4. https://doi.org/10.1074/jbc.274.31.21491
- Nicholson B, Theodorescu D (2004). Angiogenesis and prostate cancer tumor growth. J Cellular Biochemistry, 91, 125-50. https://doi.org/10.1002/jcb.10772
- Nonsrijun N, Mitchai J, Brown K, et al (2013). Overexpression of matrix metalloproteinase 11 in Thai prostatic adenocarcinoma associated with poor survival outcome. Asian Pac J Cancer Prev, 14, 3331-5. https://doi.org/10.7314/APJCP.2013.14.5.3331
- Pei D, Majmudar G, Weiss SJ, (1994). Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3. J Biol Chem, 269, 25849-55.
- Roscilli G, Cappelletti M, Vitis CD, et al (2014). Circulating MMP11 and specific antibody immune response in breast and prostate cancer patients. J Translational Med, 12, 54. https://doi.org/10.1186/1479-5876-12-54
- Rundhaug JE (2005). Matrix metalloproteinases, angiogenesis, and cancer. J Cell Mol Med, 9, 267-85. https://doi.org/10.1111/j.1582-4934.2005.tb00355.x
- Sinha AA, Quast BJ, Reddy PK, et al (2004). Microvessel density as a molecular marker for identifying high-grade prostatic intraepithelial neoplasia precursors to prostate cancer. Experimental and Molecular Pathology, 77, 153-9. https://doi.org/10.1016/j.yexmp.2004.04.005
- Taille Adl, Katz AE, Bagiella E, et al (2000). Microvessel density as a predictor of PSA recurrence after radical prostatectomy a comparison of CD34 and CD31. Am J Clin Pathol, 113, 555-62. https://doi.org/10.1309/02W2-KE50-PKEF-G2G4
- Tang Y, Nakada MT, Kesavan P, et al (2005). Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases. Cancer Res, 65, 3193-9.
- Tuamsuk P, Nonsrijun N, Pachirat K, et al (2011). Prostate cancer in Srinagarind Hospital. Srinagarind Med J, 26, 373-6.
- van Moorselaar RJ, Voest EE (2002). Angiogenesis in prostate cancer: its role in disease progression and possible therapeutic approaches. Molecular and Cellular Endocrinology, 197, 239-50. https://doi.org/10.1016/S0303-7207(02)00262-9
- Weidner N, Carroll PR, Flax J, et al (1993). Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol, 143, 401-9,
- Yodavudh S, Tangjitgamol S, Puangsa-art S (2008). Prognostic significance of microvessel density and mast cell density for the survival of Thai patients with primary colorectal cancer. J Med Assoc Thai, 91, 723-32.
- Zhao ZS, Chu YQ, Ye ZY, et al (2010). Overexpression of matrix metalloproteinase 11 in human gastric carcinoma and its clinicopathologic significance. Hum Pathol, 41, 686-96. https://doi.org/10.1016/j.humpath.2009.10.010
피인용 문헌
- Insights into the distinct roles of MMP-11 in tumor biology and future therapeutics (Review) vol.48, pp.5, 2016, https://doi.org/10.3892/ijo.2016.3400